The Director General of Treatment at Iran’s Anti-Narcotics Headquarters announced testing of a new drug that is implanted subcutaneously in the arm or forearm of addicted individuals.
This drug gradually releases substances that help the person maintain stable physical and behavioral balance throughout the day and distance themselves from high-risk consumption cycles.
He added that this method breaks the cycle of repetition, hangout visits, injection with shared syringes, overdose, and transmission of infectious diseases while simultaneously reducing supply and black market drug trafficking.
However, the drug is still in the testing phase and the final pathway and cost coverage methods require further decisions.
Abbasi noted that with this method, when individuals are not forced to spend significant time and money obtaining and consuming drugs, they are less exposed to committing crimes, theft, or falling into cycles of social destruction.
Additionally, by reducing hangout visits, the likelihood of disease transmission and formation of contaminated clusters decreases.
